| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1df20e5501d8d5de4d29d242c2d42778 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 |
| filingDate |
2020-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_242faab0a9e9d49221b6a5f1a016cda6 |
| publicationDate |
2022-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3982943-A1 |
| titleOfInvention |
Combination treatments for central nervous system disorders |
| abstract |
The inventions relate to compositions and methods for treating or preventing disorders of the central nervous system comprising administering to a patient, separately or in combination, an agent capable of normalizing copper levels and/or values and an agent capable of normalizing vitamin B5 levels, including in Alzheimer's disease patients. |
| priorityDate |
2019-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |